October 04, 2010 11:56 ET

Increasing Demand for Monoclonal Antibodies & Recombinant Proteins Drives Growth & Innovation

ROCKVILLE, MD--(Marketwire - October 4, 2010) - has announced the addition of GBI Research's new report "Manufacturing of Biologics -- Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies" to their collection of Biotechnology market reports. For more information, visit

The biologics industry has emerged as a major growth area in the global healthcare industry. Since its emergence in the 1970s, the biologics industry has grown rapidly to reach approximately $128 billion in 2009.

GBI Research's analysis suggests that the biologics drugs market has outperformed the pharmaceutical market in the past few years. The biologics industry had a year on year average growth rate of approximately 11.5% over the period of 2007-2009. This is significantly higher than the pharmaceutical industry's growth rate of 6% in the same time period. It is expected to grow by 9.3% for the period of 2009-2016.

The use of CMOs is one of the most significant trends in the healthcare industry, especially in the biologics market. CMOs will be used for most of the processes in the industry. Although the CMO market is not growing much at the moment due to capacity expansions by major companies such as Lonza Group Ltd., Boehringer Ingelheim (BI), and many more. Their focus has been shifted towards setting up new plants and buying new equipment.

These expansion processes indicate the future prospects of the industry. Many experts in the industry have already predicted that the future of the CMO market is bright. Several players from emerging countries are entering the market. Companies are opening up beginning operations in emerging countries such as India, China, and Singapore.

GBI Research suggests that the CMO biologics market is set to grow at a CAGR of 13.4%, (2009-16) which is faster than the overall CMO market.

For more information, visit

Contact Information